Drug-drug network based on similarity of molecular fingerprint

Huadong Ligong Daxue Xuebao/Journal of East China University of Science and Technology

Volumn 38, Issue 3, 2012, Pages 301-306

  Ye, Hao ^a,b   Tang, Kai Lin ^b   Li, Yi Xue ^a,b  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SHANGHAI CENTER FOR BIOINFORMATION TECHNOLOGY   (China)

Author keywords

Drug new indication prediction; Drug drug network; Molecular fingerprint

Indexed keywords

EID: 84865285498     PISSN: 10063080     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Ashburn T T, Thor K B. Drug repositioning: Identifying and developing new uses for existing drugs[J]. Nature Reviews Drug Discovery, 2004, 3(8): 673-683.
2. Chong C R, Sullivan D J Jr. New uses for old drugs[J]. Nature, 2007, 448(7154): 645-646.
3. Keiser M J, Setola V, Irwin J J, et al. Predicting new molecular targets for known drugs[J]. Nature, 2009, 462(7270): 175-181.
4. Langer T, Wolber G. Pharmacophore definition and 3D searches[J]. Drug Discovery Today: Technologies, 2004, 1(3): 203-207.
5. Knox C, Law V, Jewison T, et al. DrugBank 3.0: A comprehensive resource for 'omics' research on drugs[J]. Nucleic Acids Research, 2011, 39(1): D1035-1041.
6. O'Boyle N M, Banck M, James C A, et al. Open Babel: An open chemical toolbox[J]. Journal of Cheminformatics, 2011, 3: 33.
7. Willett P, Barnard J M, Downs G M. Chemical similarity searching[J]. Journal of Chemical Information & Computer Sciences, 1998, 38(6): 983-996.
8. Johnson A M, Maggiora G M. Concepts and Applications of Molecular Similarity[M]. New York: John Willey & Sons, 1990: 1-2.
9. Iida A, Kano M, Kubota Y, et al. Podophyllotoxin aza-analogue, a novel DNA topoisomerase II inhibitor[J]. Chemical & Pharmaceutical Bulletin, 2000, 48(4): 486-489.
10. Zhang Y L, Shen Y C, Wang Z Q, et al. Antitumor agents, 130, novel 4 beta-arylamino derivatives of 3', 4'-didemethoxy-3', 4'-dioxo-4-deoxypodophyllotoxin as potent inhibitors of human DNA topoisomerase II[J]. Journal of Natural Products, 1992, 55(8): 1100-1111.
11. Terada T, Fujimoto K, Nomura M, et al. Antitumor agents: I. DNA topoisomerase II inhibitory activity and the structural relationship of podophyllotoxin derivatives as antitumor agents[J]. Chemical & Pharmaceutical Bulletin, 1992, 40(10): 2720-2727.
12. Gillis J C, Brogden R N. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria[J]. Drugs, 1995, 49(3): 467-484.
13. Malvisi Stracciari J, Venturini A P, Anfossi P, et al. Sensitivity to rifaximin and rifampicin of Mycobacterium tuberculosis isolated from guinea pigs treated orally with rifaximin[J]. Chemioterapia: International Journal of the Mediterranean Society of Chemotherapy, 1987, 6(2): 82-84.